Met uw toestemming gebruiken we privacyvriendelijke, beperkte analyses om te begrijpen welke onderzoeksroutes werken. We gebruiken geen advertentietrackers of sessieopnamen. U kunt deze keuze wijzigen in Voorkeuren. Lees het Privacybeleid.
Quote this valuation with its source: Fair value, Potential value and the price at analysis.
FAQ
ECL — frequently asked questions
Is Ecolab Inc. overvalued?
In our latest published analysis dated 2026-10-03, ECL looks meaningfully overvalued. The price recorded at analysis is USD 274 versus our fair value of USD 204; the high endpoint is presented separately as potential value of USD 252. That implies roughly 25.5% downside to fair value at that date.
Our latest published report, analyzed 2026-10-03, gives ECL a fair value of USD 204 and a potential value of USD 252. The conclusion is triangulated across multiple valuation models and weighted by reliability for Ecolab Inc.'s archetype; it is a dated research output, not a live price.
Should I buy ECL now?
Our latest published rating for ECL, analyzed 2026-10-03, is Sell. Ecolab Inc. looks meaningfully overvalued at the analysis-date price of USD 274 versus fair value of USD 204; potential value is USD 252. This is research for educational purposes, not personalized investment advice.
What are the biggest risks for ECL?
The dedicated bear-case section in our report analyzed 2026-10-03 documents Ecolab Inc.'s material risks, evidence, thresholds, and thesis-invalidation conditions. Scenario-specific explanations remain in that section so the report does not repeat or decontextualize them elsewhere.
What is ECL's rating?
Our latest published rating for ECL, analyzed 2026-10-03, is Sell, with a published moat assessment of 9/10 (Wide). It reflects our fair value of USD 204, the potential value of USD 252, and the price recorded at analysis (USD 274).
Engelse bron wordt weergegeven terwijl we vertalen
Dit rapport is nog niet vertaald. Vernieuw over een paar minuten zodra de vertaalwachtrij is bijgewerkt.
§1 SamenvattingEN
Antwoord in 30 secondenSell
Koers versus waarde
Koers
$273.70
Reële waarde
$203.99
Potentiële waarde
$251.65
Per
2026-10-02
Waarom het kan werken
Accelerating scaling of the global high-tech platform toward $4 billion in revenue by 2030 at a 25% operating income margin, powered by rapid adoption of CoolIT liquid cooling solutions in AI datacenters and debottlenecked bioprocessing purification capacity in China.
Wat onze visie zou veranderen
Water Services annual revenue growth decelerating below 2.0% YoY.
Ecolab Inc. While the company commands a Wide economic moat driven by high switching costs in Water Services and over 800,000 connected IoT sensors, the equity trades at 29.67x forward earnings —an unsustainable valuation premium that leaves investors completely unprotected against industrial demand deceleration or persistent commodity inflation.4,5
Ecolab is a premier specialty service and technology business with enduring competitive advantages. In FY2025, consolidated revenue reached $16,081.2M and operating income reached $2,737.6M (17.02% margin). The company generated $2,952.6M in and $1,904.3M in after funding $1,048.3M in . Water Services generated $7,679.9M (47.8% of revenue), and Global Institutional contributed $5,962.0M, forming a highly defensive consumable base.
Despite these outstanding structural qualities, current market pricing has decoupled from fundamental earnings power. At $273.70 per share, Ecolab trades at 29.67x NTM earnings. This stands at a 10.4-multiple premium over industrial gas peer APD (19.23x forward P/E) and significantly above Linde at 24.51x and Sherwin-Williams at 23.54x. In present-value terms, our fundamental fair value midpoint of $203.99 sits 31.6% below the present-value equivalent of the 12-month analyst consensus target ($298.06 PV, derived from undiscounted target $324.95 at Ke 9.0231%).3,4
Our multi-model valuation framework balances forward earnings power ($214.84 midpoint) and 10-year moat fade economics ($224.69 midpoint) against enterprise cash flow models that incorporate Ecolab's $8,783.1M net debt ($139.15 DCF midpoint). Even under an aggressive Bull scenario where high-tech liquid cooling accelerates toward $4B by 2030, equity value reaches only $251.65—still 8.06% below the October 2, 2026 price of $273.70. With risk-reward heavily tilted to the downside (-25.47% implied return), we recommend selling into strength.4,5
Mission-Critical Water Services Consumable Resilience
Water Services represents 47.8% of revenue ($7,679.9M in FY2025), delivering essential water purification and cooling tower treatments that customers cannot easily cancel or defer.8
Rapid Value-Pricing Realization and Digital Stickiness
Proprietary formulations and over 800,000 connected IoT devices allow Ecolab to pass through cost inflation within three months, defending gross margins far faster than peers.5
High-Tech Datacenter Cooling and Bioprocessing Debottlenecking
Integration of CoolIT expands data center addressable opportunity by 3x to 5x, while the newly commissioned China purification plant eliminates volume bottlenecks to drive double-digit growth toward a 30% ROI target.5
Huisaanbeveling
Sell. Ecolab is an outstanding wide-moat compounder whose equity valuation has become severely extended at 29.67x forward P/E, trading 34.17% above fundamental fair value of $203.99. Investors should trim into current strength to harvest gains.4
Bedrijfsoverzicht
The majority of its Pest Elimination revenue is from services and is recognized when the services are provided, which is over time. Through this strategy and the breadth of its product and service mix, one customer may utilize the offerings of several of its operating segments. Important in its value proposition for customers is its ability to produce improved results while reducing their water and energy use. Its manufacturing facilities produce chemical products and equipment for all its operating segments, although Pest Elimination purchases the majority of their products and equipment from outside suppliers. Its chemical production process consists of blending purchased raw materials into finished products in powder, liquid, and solid form.
Additionally, intermediates from reaction chemistries are used in some of the blends and are also packaged directly into finished goods.
§2 BerenscenarioEN
Under an adverse combination of cyclical manufacturing contraction, persistent high-single-digit raw material inflation, and debt refinancing pressures across Ecolab's $9,429.3M total debt obligation, consolidated operating margin would fall below 16.5% and revenue growth would stall below 2.0%. In this environment, free cash flow generation from the FY2025 baseline of $1,904.3M would be impaired while the market's elevated forward P/E of 29.67x de-rates toward peer medians (19.2x to 21.4x), confirming substantial downside toward the lower fair value boundary of $156.25.
Water Services annual revenue growth slows below 2.0% due to manufacturing capacity cutbacks
High-single-digit raw material inflation compresses operating margin below 16.5%5
Valuation multiple de-rates from 29.67x toward mature specialty materials peer median of 21.4x3
A global industrial manufacturing downturn contracts Water Services demand, persistent commodity input cost inflation overwhelms customer pricing acceptance, and multiple de-rating toward peer medians drives fair value down to the lower boundary of $156.25.
Hoe deze these kan breken
Industrial manufacturing recession and Water Services volume contraction
Water Services delivered $7,679.9M in FY2025, accounting for 47.8% of consolidated sales ($16,081.2M). If global heavy industry and manufacturing utilization undergo a sustained contraction, industrial water consumption slows markedly, depressing segment revenue growth below 2.0% YoY and driving an estimated -28.5% fair value impairment.7,8
FV impact
-4%
Revenue and EPS growth 5 points lower for five years
Trigger
Within 12 months
Vroege waarschuwingssignalen om te volgen
De vijf ontwikkelingen die onze beleggingsthese zouden verzwakken.
Ecolab commands a wide economic moat rooted in high switching costs and proprietary chemistry that differentiates its business model from standard industrial chemical manufacturers. Rather than competing as an unbundled bulk chemical distributor, Ecolab couples customized chemical treatments with proprietary automated feed equipment and continuous digital monitoring systems, including AquaIQ, DishIQ, and 3D TRASAR. With more than 800,000 deployed IoT devices scaling past 1,000,000, the company's hardware and telemetry are deeply integrated into customers' primary water cooling, heating, and hygiene infrastructures.
The mission-critical nature of Ecolab's solutions creates powerful operational lock-in. Water treatment and infection prevention represent an immaterial fraction of a manufacturing facility's or hospital's total operational budget, yet chemical imbalances or microbiological contamination can trigger catastrophic facility shutdowns, regulatory penalties, or equipment corrosion. Consequently, enterprise clients face prohibitive friction and operational risk when contemplating a vendor switch. This entrenchment is reflected in Ecolab's ability to implement value pricing that offsets input cost inflation rapidly, compressing what used to be a two-year recovery cycle into a single quarter.
Furthermore, the company's debottlenecked purification manufacturing facility in China eliminates prior capacity limitations, opening a high-return growth vector in bioprocessing and pharmaceutical filtration targeted toward a 30% ROI. These structural moats allow Ecolab to generate an ROIC of 13.84%, comfortably exceeding its computed WACC of 8.3627%. However, this wide economic moat does not insulate public equity holders from valuation multiple overextension at the October 2, 2026 price of $273.70.
Economische winst
Ecolab generates an ROIC of 13.84% (with historical levels at 11.61%), comfortably exceeding its computed WACC of 8.3627%. This spread of approximately 5.48 percentage points demonstrates verified economic profit generation, supported by a 44.51% gross margin ($7,158.1M on $16,081.2M revenue) in FY2025.2,4,7
9/ 10
Wide
Sources of advantage
01Switching Costs via Embedded On-Site Dosing Systems and Digital IoT Telemetry — Ecolab embeds proprietary dispensing machinery, 3D TRASAR digital automation, and over 800,000 active telemetry devices expanding to over 1,000,000 units by year-end. Replacing Ecolab requires complete system re-engineering, plant downtime, and regulatory re-certification across customer cooling and boiler circuits.Wide
02Intangible Assets and Specialized Purification Chemistry Formulations — Ecolab holds extensive proprietary chemical intellectual property for specialized bioprocessing resin purification, antimicrobials, and closed-loop liquid cooling telemetry (CDU integrating 3D TRASAR), paired with global brand reputation in mission-critical hygiene and water preservation.Wide
Bekende bedreigingen voor het concurrentievoordeel
Bedreiging
Ernst
Tijdlijn
Beperking
High-single-digit raw material commodity inflation persisting through the second half of 2026.
high
6-18 months
Value pricing structures and multi-year service contracts structured to capture price adjustments rapidly.5
The highlighted cell is Fair value when every assumption sits at its base level ($203.99). Each row and column shows what Fair value becomes when one assumption moves.
Free cash flow to the firm stays positive in the first projected year at $2.1B after modeled reinvestment of $527.3M, with terminal value at 78.1% of enterprise value. A sudden drop in free cash flow is not projected unless capital spending relative to revenue, reinvestment, or gross margin resets materially.
Ecolab executes cleanly on its core operational targets: Water Services preserves steady consumable pricing and volume replenishment, operating margins expand toward guided targets, and China debottlenecking supports steady bioprocessing demand. However, even under this successful operating performance, fundamental cash flows yield Fair value of $203.99, indicating that shares at $273.70 reflect an implied return of -25.5%.4,5,8
Operating margin reaches 20.5% by FY2028 supported by high-tech mix shift and rapid value pricing5
§7 Beslissingsboom voor winstenEN
Overtroffen
Upgrade the rating; Re-examine operating margin progression against guided management targets and audit volume recovery in Water Services before adjusting underweight allocations.
A revenue and EPS beat validates pricing resilience, but given that shares trade at $273.70 against Fair value of $203.99, fundamental cash flows remain insufficient to warrant an aggressive change in stance.
Conform
Maintain Sell; Maintain existing capital preservation posture; review input cost commodity inflation and monitor integration milestones for acquired platforms.
Trigger: FY2026 EPS between $8.05 and $8.25 and 2H operating margin at approximately 19.0%5
Inline results confirm baseline earnings expectations but leave shares at $273.70 at a substantial premium over Fair value of $203.99, maintaining an implied return of -25.5%.
An earnings or margin miss exposes the vulnerability of trading at a forward P/E of 29.67x, increasing the likelihood of multiple compression toward peer medians.
Cash flow conversion is robust. For FY2025, operating cash flow reached $2,952.6M and free cash flow stood at $1,904.3M after deducting $1,048.3M in capex. FCF converted 69.56% of operating income ($2,737.6M) and 91.75% of GAAP net income ($2,075.6M). High cash conversion is sustained by the consumable nature of water treatment chemicals and hygiene products. Working capital demands remain manageable, but commodity inflation could temporarily dampen conversion if inventory carrying costs rise.
ROIC is projected to expand organically by at least 100 basis points annually according to management, overcoming short-term denominator expansion caused by the CoolIT acquisition to return to pre-acquisition levels by 2028. The commissioning of debottlenecked purification manufacturing in China provides high-margin capacity targeting a 30% ROI, which will support structurally higher returns on capital over the next five years.
Ecolab's ROIC of 13.84% exceeds its computed WACC of 8.3627% by 5.48 percentage points, confirming substantial economic value creation across its core operating divisions.
Ecolab Inc. (ECL) trades at 29.7x forward earnings against a peer median of 21.4x. Its EV/EBITDA of 20.7x compares with a peer median of 17.7x. The comparison uses 4 peers: The Sherwin-Williams Company, Air Products and Chemicals Inc., Linde plc and Freeport-McMoRan Inc., as of 2026-10-03.
§10 Sector & cyclusEN
Cyclusfase
Expansion
Across the specialty chemical and basic materials benchmark, industry capex-to-revenue stands at 4.10% and industry capex-to-depreciation is 1.55x. Ecolab invested $1,048.3M in capex during FY2025 on $16,081.2M revenue (6.52% capex/revenue) against D&A of $672.6M (1.56x capex/depreciation).7
Bullencyclus
In an industrial upcycle, manufacturing capacity utilization expands, semiconductor fabrication plants scale, and AI data centers proliferate, driving surging demand for ultrapure process water and liquid cooling distribution units (CDUs). Ecolab leverages pricing power and operating leverage to expand margins toward 20%, while high-tech revenues scale toward their $4B 2030 target.
Berencyclus
In a downcycle or manufacturing recession, industrial facility utilization contracts, diminishing demand for boiler, cooling, and wastewater process chemicals. When clients cut operating budgets, value pricing pushbacks intensify, squeezing Ecolab's operating margin from its FY2025 level of 17.02% and triggering equity de-rating toward mature chemical peer multiples.
Seculaire trends
Trend
Impact
Notitie
Global Industrial Water Conservation and Reuse Mandates
positive
Increasing freshwater scarcity and environmental regulations compel industrial facilities to recycle and treat process water, sustaining recurring demand for Water Services ($7,679.9M in FY2025).
AI Data Center Liquid Cooling Adoption
positive
High-density artificial intelligence computing infrastructure necessitates direct-to-chip liquid cooling and cooling distribution units (CDUs), expanding Ecolab's addressable opportunity by 3x to 5x through CoolIT.
Positionering
Ecolab holds the leading global market position in commercial water treatment and institutional hygiene. Compared to capital-intensive industrial gas peers such as Air Products & Chemicals (operating margin 25.54%, forward P/E 19.23x) and Linde plc (operating margin 28.12%, forward P/E 24.51x), Ecolab operates a higher-turnover, consumable-focused service model. Its embedded service personnel and digital telemetry create stickier customer relationships, though current equity pricing at 29.67x forward P/E leaves no margin for cyclical underperformance.3,4
§11 PositiebeheerEN
Positiegrootte
0%
Ecolab shares trade at $273.70, representing a 34.17% premium to our synthesized intrinsic fair value of $203.99 and delivering an implied return of -25.47%. The stock trades at 29.67x forward P/E, well above mature peer medians (19.2x to 21.4x). Under our house Sell rating, recommended portfolio exposure is 0%.3,4
Risico
Risk management dictates strict avoidance of long exposure and systematic portfolio trimming under the current Sell recommendation. While Ecolab possesses high business quality and a wide economic moat, paying 29.67x forward P/E for a business carrying $9,429.3M in debt and facing high-single-digit input cost inflation exposes capital to severe downside asymmetric risk. Trim positions into any liquidity rallies and redeploy capital into assets offering positive margin-of-safety spreads.
Entree-tranches
Niveau
Actie
Waarom
$203.99
Re-evaluate risk-reward profile and fundamental growth trajectory
Represents the synthesized fair value midpoint, eliminating the current 34.17% market price premium.
Consider initiating initial baseline exposure with adequate margin of safety
Represents the lower boundary of the fundamental fair value range, offering sufficient downside protection against cyclical manufacturing shocks.
Exit-tranches
Niveau
Actie
$220.00
Cover initial portion of short or harvest capital reallocation gains
$203.99
Fully close short or complete position exit as market reaches fundamental fair value
Ecolab trades at 29.67x NTM earnings and a 34.17% premium to fundamental fair value ($203.99). The risk-reward asymmetry is heavily negative, with DCF-derived values of $139.15 indicating deep valuation vulnerability if margin milestones stumble.4
Income & Total Return Investor
Avoid
An annualized dividend payout of $2.92 per share yields roughly 1.07%, offering negligible downside defense against an implied equity return of -25.47% toward fair value.4
Tactical / Growth Investor
Avoid
Even after upward FY2027 estimate revisions, the stock's forward P/E multiple is elevated at 29.67x versus peers LIN (24.51x) and APD (19.23x). Any operational friction will cause rapid multiple contraction without growth acceleration.3
Ecolab trades at 29.67x forward P/E, a 10.4-multiple premium over peer APD (19.23x). Any industrial manufacturing deceleration or commodity inflation risks margin compression and sharp multiple de-rating toward fundamental cash flow models ($139.15 to $180.24). Investors should sell into current strength.
§15Your notes
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
Private notes
Visible only to you. Synced to this device.
0 chars
Sources
The records this analysis drew on, as they stood when it was run.
Analyst consensusData as of 2026-10-03 · Published 2026-10-03 · Provider-adjusted · cited for 2 figuresCited in Scenario's
Not every cited input appears here: internal calculations and intermediate model outputs have no external record, and some citations could not be matched to one.
Severe raw material cost inflation outpaces price realization
Consolidated FY2025 EBIT margin was 17.02% ($2,737.6M EBIT on $16,081.2M revenue). Management indicated expectations of high-single-digit raw material commodity inflation for the balance of the year alongside a 60 bps gross margin drag from Ovivo. If customer resistance prevents rapid value pricing recovery and operating margin falls below 16.5%, earnings power faces a -24.0% fair value impact.5,7
FV impact
-1.9%
Operating margin 3 points lower throughout
Trigger
Within 18 months
Valuation multiple de-rating toward mature specialty materials peer median
Ecolab trades at a forward P/E multiple of 29.67x, representing an expansive premium over peer Air Products & Chemicals at 19.23x and peer median levels of 21.38x. Any growth stumble or failure to reach guided 20% operating margins by 2027 risks compressing the valuation multiple toward 21.4x, triggering a -21.5% fair value decline.3,4,5
Waarschuwing alsHealthcare and Life Sciences segment revenue growth below 5.0% YoY
05
Valuation Forward P/E multiple relative to specialty materials peers
Multiple de-rating toward peer median triggered by decelerating organic volume growth or missed operating margin targets.
Huidig:29.67x forward P/E vs peer APD at 19.23x and LIN at 24.51x
Waarschuwing alsForward P/E compressing below 21.4x peer median
Cyclical downturn in global heavy manufacturing utilization dampening Water Services consumable replenishment volumes.
medium
12-24 months
Increasing penetration of higher-margin digital monitoring platforms (Ecolab Digital targeting >20% growth) and expansion in data center liquid cooling.5
Integration drag and margin dilution from major M&A transactions, including the 60 bps gross margin drag from Ovivo and ROIC dilution from CoolIT.
Discounted forecast-period cash flows (US$ 37,29) plus discounted terminal value (US$ 133) minus signed per current share (US$ 31,33) equals the US$ 139 lens value shown above. Negative net debt is , so subtracting it raises value.
Global high-tech scales toward $4B revenue by 2030 growing over 25% annually5
China plant debottlenecking drives purification volume growth above 15% with 30% segment margins5
Rapid commercial scaling of CoolIT liquid cooling systems across AI data centers multiplies addressable sales opportunities 3x to 5x, while China purification debottlenecking sustains double-digit life sciences growth toward a 30% ROI. Value pricing overcomes raw material inflation rapidly within three months, accelerating operating margin expansion beyond 20% and driving valuation toward the upper fair value boundary of $251.65.5
Ecolab maintains a balanced capital allocation strategy prioritizing internal growth capex, disciplined bolt-on M&A, and shareholder capital return. In FY2025, capex was $1,048.3M alongside $672.6M of D&A, funding plant capacity additions in China and IoT sensor rollouts. Strategic acquisitions including CoolIT and Ovivo expand addressable high-tech capabilities, though Scott Kirkland noted that major transactions cause near-term ROICdilution before recovering by 2028. Total debt of $9,429.3M results in net debt of $8,783.1M, which requires consistent operating cash flow generation ($2,952.6M in FY2025) in an elevated interest rate environment where pre-tax debt costs stand at 5.78%.
Ecolab's service-heavy business model delivers reliable cash generation that self-funds growth reinvestment and dividend distributions.
Consolidated profitability targets require continuous pricing realization to absorb inflation.
Operating margin was 17.02% in FY2025, while management affirmed a 19% target for 2H 2026 and 20% in 2027.
Earnings growth in 2026-2027 is heavily reliant on margin expansion rather than volume growth alone, exposing results to operational execution risk.
Balance sheet leverage elevates enterprise vulnerability in an extended high-cost-of-capital regime.
Total debt of $9,429.3M creates net debt of $8,783.1M against $2,737.6M of EBIT.
While manageable, financial leverage limits aggressive share repurchases and increases earnings sensitivity to higher refinancing rates.
Linde plcLIN
Koers / reële waarde
Reële waardeUS$ 266,68Report-date priceUS$ 468,38
Beoordelingsdatum
ConcurrentievoordeelNone
Beleggingsscorekaart53 / 100
Freeport-McMoRan Inc.FCX
Koers / reële waarde
Reële waardeUS$ 32,53Report-date priceUS$ 72,31
Beoordelingsdatum
ConcurrentievoordeelNarrow
Beleggingsscorekaart59 / 100
Marge
ECL
Ecolab Inc.
$76.7B
29.7x
4.6x
20.7x
22.0%
—
SHW
The Sherwin-Williams Company
$77.6B
23.5x
3.2x
19.5x
65.1%
18.1%
APD
Air Products and Chemicals Inc.
$61.8B
19.2x
4.9x
17.6x
0.0%
25.5%
LIN
Linde plc
$221.0B
24.5x
6.2x
17.8x
18.4%
28.1%
FCX
Freeport-McMoRan Inc.
$103.5B
17.2x
4.0x
12.8x
14.8%
33.4%
Specialty Chemical Feedstock Inflation
negative
Persistent raw material commodity inflation, which management notes at high-single-digit levels, elevates working capital and challenges gross profit conversion during periods of delayed price adjustment.
Lower normalized outer-year EBIT margin assumptions across DCF models.
